Statin-associated myasthenia: A case report and literature review

Therapie. 2020 May-Jun;75(3):301-309. doi: 10.1016/j.therap.2019.07.004. Epub 2019 Jul 26.

Authors

Valérie Gras-Champel¹, Inès Masmoudi², Benjamin Batteux², Philippe-Edouard Merle³, Sophie Liabeuf², Kamel Masmoudi²

Affiliations

¹ Regional pharmacovigilance centre, division of clinical pharmacology, Amiens university hospital, 80054 Amiens, France. Electronic address: gras.valerie@chu-amiens.fr.
² Regional pharmacovigilance centre, division of clinical pharmacology, Amiens university hospital, 80054 Amiens, France.
³ Division of neurological electrophysiology, Amiens university hospital, 80054 Amiens France.

PMID: 31477339
DOI: 10.1016/j.therap.2019.07.004

No abstract available

Keywords: Adverse event; Diplopia; Myasthenia gravis; Pharmacovigilance; Statin.

Publication types

Case Reports
Letter
Review

MeSH terms

Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors